Main content

Vision and strategy

Global leader in photodynamic technology.

To improve patient care and quality of life by making solutions based on photodynamic technology accessible to patients worldwide.

Photocure has a strong academic network and has a proven track record in development, registration and commercialization of our products: Metvix® and Hexvix®/Cysview®.
Key elements of the company strategy are:

  • Build a speciality pharma company, focused on selected therapeutic areas
  • Maximize the potential of the company's Photodynamic Technology Platform – Photocure Technology®
  • Leverage our experience to develop, register and commercialize new products based on Photocure Technology®
  • Build a strong commercial platform in select territories